Introduction
Mr MH is a 70-year-old gentleman who presented to clinic prior to undergoing surgery for removal of a cancerous lesion from his caecum. MH has a significant cardiac history as follows:
• Myocardial infarction (MI) 2007 treated with angioplasty.
• Recurrent episodes of ventricular tachycardia (VT) following this, for which he had an automatic defibrillator inserted.
• ECHO in 2011 showed a dilated left ventricle with a thin, akinetic septum and apex giving moderate to severely impaired systolic function.
• Left ventricular ejection fraction (LVEF) of 22%.
• Severe shortness of breath on walking one flight of stairs and he generally mobilises with a wheelchair.
• CPX testing -anaerobic threshold of 5.1 ml/min/kg
Clinical management
During the assessment MH was informed regarding the risk of mortality and morbidity aided by the use of the P-POSSUM scoring system. He was calculated to have 38% risk of mortality and 94.5% risk of morbidity. Despite these risks, in view of the cancerous nature of the lesion, it was decided with the collaboration of the cardiology team that surgery would be performed with consultant surgeon and consultant anaesthetist lead care and elective admission to intensive care postsurgery.
As the implantable cardioverter defibrillator (ICD) had no pacing function it would be checked prior to surgery and turned off with external defibrillator pads applied in theatre. MH would be first on the list and surgery performed during working hours so that the ICD can be reactivated post-surgery.
Evidence for best practice
Clinical magnets are designed to be placed over an ICD implantation site where an appropriately positioned magnet will suspend ICD tachyarrhythmia detection without affecting the pacing mode or rate (Jacob et al 2011). However, some ICDs have idiosyncratic reactions to magnets and in particular, the St Jude's ICD manufacturers advise the use of the magnet to be placed slightly off-centre with the magnet curve over the bottom or top end of the ICD to ensure deactivation of tachyarrhythmia therapy (St Jude Medical -no date). It's concerning that this small variation in magnet placement should result in reduced effectiveness of the magnet and begs the question whether magnets should be used at all. However, although not fully reliable, magnets are convenient and immediately reversible allowing the expedition of patient care as removing the magnet causes immediate reactivation of the ICD postoperatively (Joshi 2009), although this needs to be double-checked by a technician. Magnet placement needs to be continuously monitored and if this is not possible, eg prone positioning, then reprogramming of the ICD should be performed instead to ensure patient safety.
Electromagnetic interference (EMI) is a major concern with ICDs as it can cause reprogramming, temporary inhibition or trigger pacing, battery depletion, asynchronous pacing, damage to the internal circuitry and myocardial damage causing a rise in threshold and loss of capture (Fiek et al 2004 , Porres et al 2008 Consultant in Anaesthesia, University College Hospital London, UK 2006). The ICD may also deliver inappropriate shocks due to misinterpretation of noise from EMI (St Jude Medical -no date) and can potentially create a sustained ventricular arrhythmia (Crossley et al 2011) . This can be detrimental when sudden patient movement can affect surgical precision as in intra-ocular surgery or neurosurgery (Rozner 2007) . It is recommended that electrocautery, when needed, is used in short, infrequent bursts with the minimum energy required and bipolar rather than unipolar involving surgical views (ASA 2011).
Recommendations regarding the management of ICDs intraoperatively although present are not clear to date. The American Society of Anesthesiologists (ASA) advocates the reprogramming of tachyarrhythmia therapy of ICDs prior to surgery to enable maximum patient safety. However the Heart Rhythm Society (HRS) supports the use of a magnet as long as the magnet response is known and its use is feasible (Crossley et al 2011), ie patient positioning and ability to monitor magnet position. ICD manufacturers also agree with this and recommend the use of magnets to suspend tachyarrhythmia detection (ASA 2011). The ASA and HRS statements for perioperative management of ICDs advise that disabling tachyarrhythmia therapy may not be necessary if the surgery is below the umbilicus (Crossley et al 2011) as surgery superior to the umbilicus produces the greatest risk of EMI (Porres et al 2008, Thompson & Mahajan 2013) . Keeping the tachyarrhythmia therapy active thus enables rapid detection and treatment of any tachyarrhythmic events intraoperatively.
Development of clinical practice
Preoperative discussions between the surgeon, anaesthetist and cardiologist should take place regarding the surgery suggested as well as the electrosurgical equipment that will be used to better understand the risks and decisions that can be made as to whether a magnet is a feasible option or whether reprogramming of the ICD is needed, or in some cases whether any intervention is needed at all. Independent opinion should be less relied upon and an ICD primary care team would be more appropriate for the safe management of these patients (Crossley et al 2011) . It would be worthwhile developing an algorithm for the perioperative management of these devices based on local availability of experts in ICD therapy (Thompson & Mahajan 2013) . Patients should also be informed of the risks of ICD malfunction despite the precautions that would be put in place. 
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